Synchrony Symposium
What is Synchrony?
First and only international symposium on translational research in autism that brings together academia, biotech, pharmaceutical companies, stakeholders and venture partners with the goal to catalyze scientific research that can improve the quality of life for those with neurological disorders and developmental disabilities through safe and evidence-based medicine.
An interdisciplinary forum for the brightest minds to collaborate and innovate, Synchrony features CME-accredited presentations from leading scientists and clinicians.
Who takes part?
Synchrony Symposia features presentations from leading scientists
and clinicians in the field, from Mayo Clinic to Stanford, from Europe to UCSF. In addition to talks on the latest autism research and clinical findings, our symposia also included round tables on a wide range of topics.
Where does it take place?
Synchrony 2025 will be taking place at Asilomar Conference Grounds, Monterey Bay, California. Located right on the Pacific Coast, it is a perfect place to unwind after a day of learning and networking. We invite you to take family members along and make this a memorable, relaxing weekend by the beach.
RESEARCH PRESENTATIONS
Cutting-edge topics in basic science and translational research
INDUSTRY SCIENTIFIC PRESENTATIONS
Industry leaders presenting on novel therapeutics on track for FDA approval
ROUNDTABLE DISCUSSIONS
On topics such as prevention & treatment of seizures, neuroinflammation, developing biomarkers, pathways to regulatory approval
NETWORKING OPPORTUNITIES
Networking & socializing opportunities to stimulate new connections and ideas
highlighted speakers

Jennifer Frankovich

Richard Frye

John Gaitanis

Sam Pleasure
University of California San Francisco
See all Synchrony 2025 speakers












SYNCHRONY SPONSORS
ORGANOIDS
GASTROENTEROLOGY
NEUROLOGY
TREATMENT TRIALS
BIOMARKERS
IMMUNOLOGY
GENETICS
ANIMAL MODELS
EPILEPSY & SEIZURES
NEUROINFLAMMATION
FDA APPROVAL
NOVEL THERAPEUTICS
BASIC SCIENCE
NEUROLOGY
ENDOCRINOLOGY
ORGANOIDS
GASTROENTEROLOGY
NEUROLOGY
TREATMENT TRIALS
BIOMARKERS
IMMUNOLOGY
GENETICS
ANIMAL MODELS
EPILEPSY & SEIZURES
NEUROINFLAMMATION
FDA APPROVAL
NOVEL THERAPEUTICS